Billionaire Ken Griffin Just Bought More Shares of These Unstoppable Dividend Stocks
Investors have been hit with a great deal of volatility and uncertainty in the markets lately.
Even so, these two companies are healthcare leaders that can still perform well.
Both have solid growth prospects and have increased their payouts for a combined 101 years.
10 stocks we like better than Medtronic ›
Some stock-trading platforms enable their users to automatically replicate the positions taken by experienced investors or other famous figures. Many investors might prefer to do their own research before buying shares of a company, but it's still a good idea to pay attention to some of the moves more experienced names on Wall Street make.
Take Ken Griffin, a successful money manager and the billionaire CEO of Citadel Advisors, the hedge fund he founded. During the first quarter, Griffin and his team made several moves that investors, including those seeking reliable dividend payers, should seriously consider copying. The hedge fund added shares of Medtronic (NYSE: MDT) and AbbVie (NYSE: ABBV).
Here's why these two are top options for dividend seekers.
Medtronic checks several of the boxes that dividend investors look to find. Let's consider three of them. First, the company develops and markets medical devices. As a leader in a defensive industry, Medtronic tends to perform better than most even in challenging conditions. The business is highly unlikely to go under, which means there is less risk of payout cuts. Medtronic's shares have performed slightly better than the S&P 500 this year -- despite significant volatility and fears of a recession -- while it continues to generate steady revenue and profits. That's precisely what income seekers want.
Second, Medtronic has several important growth avenues. The company is inching closer to approval in the U.S. for its Hugo device, a robotic-assisted surgery (RAS) system, in urologic procedures. That will mark the device's grand commercial entrance into the U.S. market. Medtronic should seek label expansions for it in the future. The RAS industry appears to be significantly underpenetrated. As Medtronic pointed out two years ago, less than 5% of procedures that could be performed robotically currently are. The company's Hugo system will unlock massive long-term growth opportunities and help it continue delivering consistent financial results just as it has been doing.
Third, Medtronic has an impeccable dividend track record, having grown its payouts for 48 consecutive years. Its 3.4% forward yield is above the S&P 500's average of 1.3%. Medtronic currently faces some challenges, including the threat of tariffs. It expects a net tariff hit of between $200 million and $350 million during its fiscal year 2026 (which just started). However, Medtronic is looking for ways to mitigate the impact of tariffs. For its fiscal 2026, it projected revenue growth of 5% year over year and adjusted earnings-per-share (EPS) growth of 1% at the midpoint, including the impact of tariffs.
These trade developments will harm the company in the short term, but Medtronic should find ways to minimize the negative impact in the long term if these tariffs remain in place for an extended period, which is by no means certain. In my view, even with that threat, Medtronic remains a top stock to buy and hold for the long term, especially for dividend seekers.
AbbVie's shares fell off a cliff in November after an otherwise promising pipeline program flopped in a phase 2 study. The drugmaker is no stranger to clinical setbacks. No pharmaceutical giant is. However, AbbVie's underlying business still looks incredibly solid. The company's revenue and earnings are growing at a good clip largely thanks to its two immunology superstars, Skyrizi and Rinvoq. Management expects these medicines to hit $31 billion in combined sales by 2027 (versus $17.7 billion last year).
However, AbbVie's greatest strength isn't its current lineup of immunology medicines. It's the company's ability to overcome clinical setbacks and major patent cliffs by successfully developing newer and better medicines. Skyrizi and Rinvoq helped AbbVie move beyond Humira, its former top-selling medicine, which lost U.S. patent exclusivity in January 2023.
Skyrizi and Rinvoq overlap with many of Humira's indications, sometimes with greater efficacy. AbbVie's deep pipeline should enable it to develop successors to its current crop of drugs even if it has to endure setbacks along the way. AbbVie's business is impressive and so is its dividend history. The company has increased its payouts for 53 consecutive years -- making it a Dividend King -- and currently offers a forward yield of 3.6%.
AbbVie is an outstanding dividend stock despite the issues it has encountered in the past two years.
Before you buy stock in Medtronic, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Medtronic wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $656,825!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $865,550!*
Now, it's worth noting Stock Advisor's total average return is 994% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join .
See the 10 stocks »
*Stock Advisor returns as of June 2, 2025
Prosper Junior Bakiny has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends AbbVie. The Motley Fool recommends Medtronic and recommends the following options: long January 2026 $75 calls on Medtronic and short January 2026 $85 calls on Medtronic. The Motley Fool has a disclosure policy.
Billionaire Ken Griffin Just Bought More Shares of These Unstoppable Dividend Stocks was originally published by The Motley Fool
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
1 Magnificent Pipeline Stock Down Nearly 20% to Buy and Hold Forever
At its current share price, Energy Transfer's distribution yields more than 7%, and the payouts have been growing. It has greatly improved its balance sheet and contract structure over the past few years. The master limited partnership has strong growth opportunities ahead of it. 10 stocks we like better than Energy Transfer › One of my favorite pipeline stocks to buy right now is Energy Transfer (NYSE: ET), and investors can pick up the master limited partnership (MLP) on sale, with shares trading down nearly 20% from their high as of this writing. In fact, the stock is one of my largest holdings. Here's why Energy Transfer is a great stock to buy and hold for the long term. Energy Transfer has built one of the largest integrated midstream systems in the U.S., handling the transport, storage, and processing of natural gas, crude oil, natural gas liquids (NGLs), and refined products. Its scale enables it to benefit from rising volumes across the energy value chain, as well as take advantage of price spreads across regions, seasons, and products. For instance, natural gas prices often rise in winter and can vary across the country. Energy Transfer can profit by storing gas ahead of periods of peak demand or by moving it from lower-priced to higher-priced markets. The company also upgrades certain hydrocarbons into more valuable end products. This kind of integrated footprint is hard to replicate, and it makes growth opportunities easier to take advantage of. With a strong position in Texas and the Permian Basin, Energy Transfer has access to low-cost associated gas, putting it in a solid spot to benefit from trends like the country's rising liquefied natural gas (LNG) exports and growing electricity demand tied to the AI infrastructure build-out. Given the opportunities in front of it, Energy Transfer has transitioned into growth mode. It plans to spend around $5 billion in growth capital expenditures (capex) this year, up from $3 billion in 2024. One of its major projects is the Hugh Brinson pipeline, which will transport natural gas out of the Permian to help meet growing natural gas demand in Texas stemming from new AI data center construction. It also signed a deal with data center developer Cloudburst to directly provide natural gas to its AI-focused data center development in central Texas. The company has also received inquiries from more than 60 power plants regarding new connections in 14 states, and requests from more than 200 data centers. Energy Transfer also appears ready to make a final investment decision on its long-awaited Lake Charles, Louisiana, LNG facility. It signed a deal with MidOcean Energy to fund 30% of the project's construction costs in exchange for 30% of the facility's LNG production if the project goes through, while it has also signed several sale and purchase agreements with potential customers. Demand for LNG continues to grow rapidly, with much of the new demand coming from Asia. Shell recently projected that global LNG demand could climb by 60% by 2040, driven both by Asian growth and a broader push for lower-emission energy sources for segments like heavy industry and transportation. Energy Transfer is also in a strong financial position. Building pipelines and other midstream assets is a capital-intensive business, and in 2020, the company cut its distribution in half to reduce leverage and improve its balance sheet. However, its distribution is now above where it was before that cut, and its leverage ratio is toward the low end of its target range of 4 to 4.5 times its adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization). In fact, the company recently said it was in the best financial shape in its history. On top of its solid balance sheet, the MLP is also in a good position from a contract standpoint. This year, it expects about 90% of its EBITDA to come from fee-based services, meaning it's largely insulated from swings in commodity prices and spread differentials. Additionally, the company said it now has its highest-ever percentage of take-or-pay contracts, which means it gets paid whether or not customers actually use its services. Fee-based contracts with take-or-pay provisions increase the stability of its cash flows and support its distributions. Currently, the company is paying a quarterly distribution of $0.3275 per share, which at recent share prices is good for a forward yield of 7.3%. Management has said it's looking to grow its distribution by 3% to 5% annually. The distribution is well covered. Its distributable cash flow (operating cash flow minus maintenance capex) was more than twice its distribution last quarter. In addition to Energy Transfer being in a strong financial position with growing opportunities, the stock is also cheap on both a historical and relative basis, trading at a forward enterprise-value-to-EBITDA multiple of just 8. Between 2011 and 2016 (before the pandemic), midstream MLPs traded at an average multiple of 13.7, and the stock currently trades at a lower valuation than most of its peers. Now, Energy Transfer is not a risk-free investment. The company carries debt, and falling commodity costs and macroeconomic headwinds can take a toll on fossil fuel volumes. However, given its improved contract structure and balance sheet, along with its current growth opportunities, Energy Transfer's stock should provide investors with both an increasing income stream and solid price appreciation potential. That makes it a magnificent stock to buy and hold for the long run. Before you buy stock in Energy Transfer, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Energy Transfer wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $674,395!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $858,011!* Now, it's worth noting Stock Advisor's total average return is 997% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Geoffrey Seiler has positions in Energy Transfer, Enterprise Products Partners, and Western Midstream Partners. The Motley Fool recommends Enterprise Products Partners. The Motley Fool has a disclosure policy. 1 Magnificent Pipeline Stock Down Nearly 20% to Buy and Hold Forever was originally published by The Motley Fool
Yahoo
31 minutes ago
- Yahoo
Costco (COST) Hits $1,000-Plus; Investors Renew Stock Split Talk
Costco Wholesale (COST, Financials) is back in the spotlight after its stock climbed above $1,000, sparking fresh debate over whether the warehouse retail giant might finally split its shares. The company hasn't done so since a two-for-one split in 2000. Warning! GuruFocus has detected 7 Warning Sign with COST. The stock has gained roughly 25% over the past 12 months and closed Friday near $1,040, joining a short list of S&P 500 companies with four-digit share prices. Oppenheimer analysts reiterated their bullish stance last week, raising the prospect of a potential split as a near-term catalyst. They assigned a $1,130 price target, above the Wall Street consensus. Costco's management hasn't ruled it out. CEO Ron Vachris said there was nothing to report at the company's January shareholder meeting. Chief Financial Officer Gary Millerchip said on a December earnings call that the availability of fractional shares has reduced the need for a split, but acknowledged it could make the stock feel more accessible to retail investors and employees. Despite the stock's strong performance, Costco remains one of the few companies of its size not to have split shares in over two decades, even as competitors like Walmart (WMT, Financials), and Amazon (AMZN, Financials) have done so more recently. The company did not respond to media inquiries about a potential split. See insider trades for COST. Explore Peter Lynch chart. This article first appeared on GuruFocus.
Yahoo
40 minutes ago
- Yahoo
1 Brilliant Vanguard ETF to Invest $1,000 Into This June
Dividend growth stocks have historically produced the highest total returns with the lowest volatility. The Vanguard Dividend Appreciation ETF tracks an index that screens for the top dividend growth stocks. The fund has produced strong returns for investors, which could continue in the future. 10 stocks we like better than Vanguard Dividend Appreciation ETF › Vanguard has made it easy for anyone to be a passive investor. It has several passively managed exchange-traded funds (ETFs) designed to track a specific stock market index. That enables investors to buy funds with strategies that align with their objectives. Investing in dividend growth stocks is one of the smartest strategies because they've historically produced the highest total returns with the lowest volatility. That makes the Vanguard Dividend Appreciation ETF (NYSEMKT: VIG), which tracks the performance of the S&P U.S. Dividend Growers Index, a brilliant ETF to buy. It could significantly grow the value of a $1,000 investment made this June. Most investors don't fully appreciate the power of dividend payments. Since 1940, dividend income has contributed 34% of the S&P 500's total return on average, according to data by Morningstar and Hartford Funds. Further, Hartford Funds and Ned Davis Research have found that since 1973, the average dividend payer in the S&P 500 has delivered a 9.2% average annual total return, more than double the return of non-dividend payers (4.3%). Dividend payers also had much lower volatility than non-dividend payers. In digging deeper into the data on dividends, Hartford Funds and Ned Davis Research uncovered that the best returns and lowest volatility came from dividend growers and initiators. They delivered an average total return of 10.2% compared to 6.8% for companies with no change in their dividend policy and a negative 0.9% average return for dividend cutters and eliminators. Given that data, investing in dividend growth stocks is a brilliant strategy. However, that's easier said than done for the average investor who doesn't have the time to actively manage a portfolio of dividend stocks. That's where Vanguard can help. The Vanguard Dividend Appreciation ETF tracks an index that screens companies for those with a consistent record of increasing their dividends for at least the past decade. It excludes the top 25% highest-yielding dividend stocks from the list because these companies tend to be at higher risk of being unable to grow their dividends (or worse, cut or eliminate their payouts), which has historically yielded lower investment returns. There are currently 338 stocks on the list. The Vanguard Dividend Appreciation ETF isn't a typical dividend ETF. Many of those funds focus on holding higher-yielding dividend stocks and cater more to income-focused investors. This fund aims to benefit from the value growth that dividend growth stocks have historically delivered. That's why its dividend yield (recently around 1.7%) is lower than many other top dividend ETFs. However, what this ETF lacks in yield, it more than makes up for in total return. Over the past 10 years, the fund has delivered an 11.5% average annual return. At that rate, it would have grown a $1,000 investment made a decade ago into nearly $3,000. That's a great return for a lower-risk investment strategy. While the fund's past performance doesn't guarantee it will produce similar returns in the future, its focus on dividend growers puts it in a strong position to meaningfully increase the value of an investment over the long term. For example, if it can deliver a 10% annual return, it could grow a $1,000 investment into nearly $17,500 in 30 years. Meanwhile, if it maintained its rate of return over the past decade (11.5%), it could grow $1,000 into over $26,000 in 30 years. The more you invest in the fund, the more money you can potentially make in the future. Adding $1,000 to your investment in this ETF each year could grow the total value to nearly a quarter of a million dollars in 30 years at an 11.5% annual rate of return. Dividend growth stocks have historically been powerful investments for those seeking to grow their wealth over time. They produce strong returns with less volatility than non-dividend payers and other dividend stocks. Because of that, the Vanguard Dividend Appreciation ETF looks like a brilliant ETF to invest $1,000 into this June. It could grow that money into a much larger future windfall. Before you buy stock in Vanguard Dividend Appreciation ETF, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Vanguard Dividend Appreciation ETF wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $674,395!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $858,011!* Now, it's worth noting Stock Advisor's total average return is 997% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Matt DiLallo has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Vanguard Dividend Appreciation ETF. The Motley Fool has a disclosure policy. 1 Brilliant Vanguard ETF to Invest $1,000 Into This June was originally published by The Motley Fool
